These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

300 related items for PubMed ID: 11249802

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A double-blind, randomized, placebo-controlled, prophylaxis study of adjunctive gabapentin for bipolar disorder.
    Vieta E, Manuel Goikolea J, Martínez-Arán A, Comes M, Verger K, Masramon X, Sanchez-Moreno J, Colom F.
    J Clin Psychiatry; 2006 Mar; 67(3):473-7. PubMed ID: 16649836
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy.
    Tohen M, Chengappa KN, Suppes T, Zarate CA, Calabrese JR, Bowden CL, Sachs GS, Kupfer DJ, Baker RW, Risser RC, Keeter EL, Feldman PD, Tollefson GD, Breier A.
    Arch Gen Psychiatry; 2002 Jan; 59(1):62-9. PubMed ID: 11779284
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Gabapentin as an adjunctive treatment in bipolar disorder.
    Young LT, Robb JC, Hasey GM, MacQueen GM, Patelis Siotis I, Marriott M, Joffe RT.
    J Affect Disord; 1999 Sep; 55(1):73-7. PubMed ID: 10512610
    [Abstract] [Full Text] [Related]

  • 7. Gabapentin augmentation therapy in bipolar depression.
    Wang PW, Santosa C, Schumacher M, Winsberg ME, Strong C, Ketter TA.
    Bipolar Disord; 2002 Oct; 4(5):296-301. PubMed ID: 12479661
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effectiveness of adjunctive gabapentin in resistant bipolar disorder: is it due to anxious-alcohol abuse comorbidity?
    Perugi G, Toni C, Frare F, Ruffolo G, Moretti L, Torti C, Akiskal HS.
    J Clin Psychopharmacol; 2002 Dec; 22(6):584-91. PubMed ID: 12454558
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Asenapine as adjunctive treatment for acute mania associated with bipolar disorder: results of a 12-week core study and 40-week extension.
    Szegedi A, Calabrese JR, Stet L, Mackle M, Zhao J, Panagides J, Apollo Study Group.
    J Clin Psychopharmacol; 2012 Feb; 32(1):46-55. PubMed ID: 22198448
    [Abstract] [Full Text] [Related]

  • 12. Valproate or olanzapine add-on to lithium: an 8-week, randomized, open-label study in Italian patients with a manic relapse.
    Maina G, Albert U, Salvi V, Mancini M, Bogetto F.
    J Affect Disord; 2007 Apr; 99(1-3):247-51. PubMed ID: 17056122
    [Abstract] [Full Text] [Related]

  • 13. Gabapentin treatment of the non-refractory bipolar spectrum: an open case series.
    Ghaemi SN, Goodwin FK.
    J Affect Disord; 2001 Jul; 65(2):167-71. PubMed ID: 11356240
    [Abstract] [Full Text] [Related]

  • 14. Adjunctive topiramate therapy in patients receiving a mood stabilizer for bipolar I disorder: a randomized, placebo-controlled trial.
    Roy Chengappa KN, Schwarzman LK, Hulihan JF, Xiang J, Rosenthal NR, Clinical Affairs Product Support Study-168 Investigators.
    J Clin Psychiatry; 2006 Nov; 67(11):1698-706. PubMed ID: 17196048
    [Abstract] [Full Text] [Related]

  • 15. Assessment of safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar mania: a 46-week, open-label extension following a 6-week double-blind study.
    Vieta E, Owen R, Baudelet C, McQuade RD, Sanchez R, Marcus RN.
    Curr Med Res Opin; 2010 Jun; 26(6):1485-96. PubMed ID: 20429835
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial.
    van der Loos ML, Mulder PG, Hartong EG, Blom MB, Vergouwen AC, de Keyzer HJ, Notten PJ, Luteijn ML, Timmermans MA, Vieta E, Nolen WA, LamLit Study Group.
    J Clin Psychiatry; 2009 Feb; 70(2):223-31. PubMed ID: 19200421
    [Abstract] [Full Text] [Related]

  • 17. Clinical experience with gabapentin in patients with bipolar or schizoaffective disorder: results of an open-label study.
    Cabras PL, Hardoy MJ, Hardoy MC, Carta MG.
    J Clin Psychiatry; 1999 Apr; 60(4):245-8. PubMed ID: 10221286
    [Abstract] [Full Text] [Related]

  • 18. A phase 2a randomised, double-blind, placebo-controlled, parallel-group, add-on clinical trial of ebselen (SPI-1005) as a novel treatment for mania or hypomania.
    Sharpley AL, Williams C, Holder AA, Godlewska BR, Singh N, Shanyinde M, MacDonald O, Cowen PJ.
    Psychopharmacology (Berl); 2020 Dec; 237(12):3773-3782. PubMed ID: 32909076
    [Abstract] [Full Text] [Related]

  • 19. Quetiapine in the treatment of acute bipolar mania: efficacy across a broad range of symptoms.
    McIntyre RS, Konarski JZ, Jones M, Paulsson B.
    J Affect Disord; 2007 Dec; 100 Suppl 1():S5-14. PubMed ID: 17391773
    [Abstract] [Full Text] [Related]

  • 20. Clinical experience using adjunctive gabapentin in treatment-resistant bipolar mixed states.
    Perugi G, Toni C, Ruffolo G, Sartini S, Simonini E, Akiskal H.
    Pharmacopsychiatry; 1999 Jul; 32(4):136-41. PubMed ID: 10505483
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.